AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

May 27, 2020

An up-to-date overview of computational polypharmacology in modern drug discovery

Expert Opinion on Drug Discovery
Rajan ChaudhariShuxing Zhang
May 22, 2020
PreprintOpen Access

Clinical predictors of COVID-19 mortality

medRxiv
A. S. YadawGaurav Pandey
May 24, 2020
Preprint

Predicting COVID-19 Pneumonia Severity on Chest X-ray with Deep Learning

arXiv Quantitative Biology
Joseph Paul CohenTim Q Duong
May 26, 2020
PreprintOpen Access

MACHINE LEARNING PREDICTION FOR COVID 19 PANDEMIC IN INDIA

medRxiv
Roseline Oluwaseun Ogundokun, J. B. Awotunde
May 21, 2020
Preprint

Repurpose Open Data to Discover Therapeutics for COVID-19 using Deep Learning

arXiv Quantitative Biology
Xiangxiang ZengFeixiong Cheng
May 25, 2020
PreprintOpen Access

COVID-19 Outcomes in 4712 consecutively confirmed SARS-CoV2 cases in the city of Madrid.

medRxiv
Sarah Heili-FradesO. Sanchez Pernaute
May 22, 2020
Preprint

Epidemiologically and Socio-economically Optimal Policies via Bayesian Optimization

arXiv Quantitative Biology
Amit ChandakPurushottam Kar
May 29, 2020
Open Access

Deep learning COVID-19 detection bias: accuracy through artificial intelligence

International Orthopaedics
Shashank VaidMohit Bhandari
May 28, 2020

Fighting COVID-19, a Place for Artificial Intelligence

Transboundary and Emerging Diseases
Sameh Hany Emile, Hytham K S Hamid
May 24, 2020

Current Applications of Artificial Intelligence for COVID-19

Dermatologic Therapy
Deepak Jakhar, Ishmeet Kaur
May 26, 2020

An AI approach to COVID-19 infection risk assessment in virtual visits: a case report

Journal of the American Medical Informatics Association : JAMIA
Jihad S ObeidLeslie A Lenert
May 27, 2020
Preprint

Mutations strengthened SARS-CoV-2 infectivity

arXiv Quantitative Biology
Jiahui ChenGuo-Wei Wei
May 27, 2020
Preprint

Targeted design of antiviral compounds against SARS-CoV-2 with conditional generative models

arXiv Quantitative Biology
Jannis BornMaría Rodríguez Martínez

Sign up to follow this feed and discover related papers.

Related Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

COVID-19 Neurologic Manifestations

COVID-19 patients frequently have neurological symptoms, which are probably caused by the virus invading the central nervous system. Symptoms range from a loss of smell and taste to serious complications such as encephalitis, many of which are associated with poor prognosis. This feed follows the latest developments and research into the neurological complications associated with COVID-19.

© 2020 Meta ULC. All rights reserved
/feed-previews/ai-driven-covid-19-management/27701fad-9e3b-40d5-b9d0-676419701c1d